Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An In Silico Analysis

Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An In Silico Analysis

The global health crisis caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of COVID-19, has resulted in a negative impact on human health and on social and economic activities worldwide. Researchers around the globe need to design and develop successful therape...

Full description

Bibliographic Details
Main Authors:	Hamza Arshad Dar, Yasir Waheed, Muzammil Hasan Najmi, Saba Ismail, Helal F. Hetta, Amjad Ali, Khalid Muhammad
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2020/8893483

Similar Items

Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2
by: Muhammad Tahir ul Qamar, et al.
Published: (2020-09-01)

Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches.
by: Muhammad Tahir Ul Qamar, et al.
Published: (2020-01-01)

Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
by: Larissa R. Gomes, et al.
Published: (2021-09-01)

Designing multiepitope subunit vaccine for Mycobacterium tuberculosis: Immunoinformatic approach
by: T. Senbadejo, et al.
Published: (2020-12-01)

Reverse vaccinology approach towards the in-silico multiepitope vaccine development against SARS-CoV-2 [version 1; peer review: 2 approved]
by: Vipul Kumar, et al.
Published: (2021-01-01)

Evaluation of Inhibitory Activity In Silico of In-House Thiomorpholine Compounds between the ACE2 Receptor and S1 Subunit of SARS-CoV-2 Spike
by: Victor H. Vázquez-Valadez, et al.
Published: (2021-09-01)

In silico analysis of SARS-CoV-2 spike glycoprotein and insights into antibody binding
by: Victor Padilla-Sanchez
Published: (2020-06-01)

Prediction of B-cell and T-cell epitopes in the spike glycoprotein of SARS-CoV-2 in Bangladesh: An in-silico approach
by: Mehedi Hasan, et al.

In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2
by: Anisha S. Jain, et al.
Published: (2021-01-01)

Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study
by: Gema Lizbeth Ramírez-Salinas, et al.
Published: (2020-11-01)

In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis
by: Azza Hanif Harisna, et al.
Published: (2021-07-01)

Designing a multi-epitope vaccine against Mycobacteroides abscessus by pangenome-reverse vaccinology
by: Hamza Arshad Dar, et al.
Published: (2021-05-01)

Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1
by: Khalid A. Alluhaybi, et al.
Published: (2021-08-01)

Spike S2 Subunit: The Dark Horse in the Race for Prophylactic and Therapeutic Interventions against SARS-CoV-2
by: Kim Tien Ng, et al.
Published: (2021-02-01)

Synthesis and Cytotoxic Activity of Novel Indole Derivatives and Their in silico Screening on Spike Glycoprotein of SARS-CoV-2
by: Perumal Gobinath, et al.
Published: (2021-05-01)

Exploring sand fly salivary proteins to design multiepitope subunit vaccine to fight against visceral leishmaniasis
by: R. Pandey, et al.
Published: (2020-12-01)

The Spike of SARS-CoV-2: Uniqueness and Applications
by: Ranjith Kumavath, et al.
Published: (2021-07-01)

Corrigendum: Synthesis and Cytotoxic Activity of Novel Indole Derivatives and Their in silico Screening on Spike Glycoprotein of SARS-CoV-2
by: Perumal Gobinath, et al.
Published: (2021-08-01)

SARS CoV-2 Spike Protein in silico Interaction With ACE2 Receptors From Wild and Domestic Species
by: Santiago Rendon-Marin, et al.
Published: (2021-02-01)

In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2
by: Farzaneh Jafary, et al.
Published: (2021-03-01)

Multiepitope-Based Subunit Vaccine Design and Evaluation against Respiratory Syncytial Virus Using Reverse Vaccinology Approach
by: Muhammad Tahir ul Qamar, et al.
Published: (2020-06-01)

Immunoinformatic approach to design a multiepitope vaccine targeting non-mutational hotspot regions of structural and non-structural proteins of the SARS CoV2
by: Vandana Solanki, et al.
Published: (2021-03-01)

Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An in silico approach
by: Santosh Kumar Behera, et al.
Published: (2021-01-01)

PSGL-1 Inhibits the Incorporation of SARS-CoV and SARS-CoV-2 Spike Glycoproteins into Pseudovirions and Impairs Pseudovirus Attachment and Infectivity
by: Sijia He, et al.
Published: (2021-12-01)

A Putative Prophylactic Solution for COVID-19: Development of Novel Multiepitope Vaccine Candidate against SARS-COV-2 by Comprehensive Immunoinformatic and Molecular Modelling Approach
by: Hafiz Muzzammel Rehman, et al.
Published: (2020-09-01)

The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines
by: Mehrdad Mohammadi, et al.
Published: (2021-07-01)

Cell-Free Hemoglobin Does Not Attenuate the Effects of SARS-CoV-2 Spike Protein S1 Subunit in Pulmonary Endothelial Cells
by: Sirsendu Jana, et al.
Published: (2021-08-01)

The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic
by: Priyanka Shah, et al.
Published: (2021-03-01)

In silico validation of potent phytochemical orientin as inhibitor of SARS-CoV-2 spike and host cell receptor GRP78 binding
by: Arijit Bhowmik, et al.
Published: (2021-01-01)

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
by: Divya M. Teli, et al.
Published: (2021-01-01)

In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin
by: Sakshi Piplani, et al.
Published: (2021-06-01)

Stabilizing the closed SARS-CoV-2 spike trimer
by: Jarek Juraszek, et al.
Published: (2021-01-01)

The Spike of Concern—The Novel Variants of SARS-CoV-2
by: Anna Winger, et al.
Published: (2021-05-01)

The effect of spike mutations on SARS-CoV-2 neutralization
by: Chloe Rees-Spear, et al.
Published: (2021-03-01)

Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening
by: Muhammad Waqas, et al.
Published: (2021-01-01)

Phytochemical Moieties From Indian Traditional Medicine for Targeting Dual Hotspots on SARS-CoV-2 Spike Protein: An Integrative in-silico Approach
by: V. Umashankar, et al.
Published: (2021-05-01)

In Silico Study of Polyunsaturated Fatty Acids as Potential SARS-CoV-2 Spike Protein Closed Conformation Stabilizers: Epidemiological and Computational Approaches
by: Alonso Vivar-Sierra, et al.
Published: (2021-01-01)

Identifying epitopes for cluster of differentiation and design of new peptides inhibitors against human SARS-CoV-2 spike RBD by an in-silico approach
by: Jihane Akachar, et al.
Published: (2020-12-01)

Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
by: Yue Zheng, et al.
Published: (2021-01-01)

Prefusion spike protein conformational changes are slower in SARS-CoV-2 than in SARS-CoV-1
by: Isu, U.H, et al.
Published: (2022)